Hydrogenated castor oil-based emollient
Emollient creams and ointments, hydrogenated castor oil-containing
Brand names: various
Adult dose
Dose: Apply liberally PRN
Route: Topical
Frequency: Multiple daily applications
Clinical pearls
- Alternative emollient base for patients intolerant to paraffin-based products
- NICE NG198 / CKS Eczema framework
- BAD: emollient choice should be patient-led where efficacy comparable
Contraindications
- Hypersensitivity
Side effects
- Local irritation
- Contact dermatitis (rare)
Monitoring
- Skin response
- Tolerance
Reference: BNF; NICE CKS Eczema; BAD; https://bnf.nice.org.uk/drugs/emollient-creams-and-ointments-hydrogenated-castor-oil-containing/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- HE-MACS (History and ECG-Based Manchester ACS Risk Score) · ACS Risk Stratification
- Weight-Based Levothyroxine Dose Calculator · Thyroid
- Number Needed to Treat (NNT) / Number Needed to Harm (NNH) · Evidence-Based Medicine
- HIV Opportunistic Infection Risk (CD4-Based) · HIV / Immunodeficiency
- Estimated Bladder Capacity (Age-based) · Urodynamics
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD